Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stage-shift cancer screening model.

R J Connor1, K C Chu, C R Smart

  • 1Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892.

Journal of Clinical Epidemiology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal interferometric measurement of femtosecond spectral phase.

Optics letters·2009
Same author

Direct measurement of the spectral phase of femtosecond pulses.

Optics letters·2009
Same author

400-Hz mechanical scanning optical delay line.

Optics letters·2009
Same author

Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.

Cytokine & growth factor reviews·2007
Same author

Severe factor X deficiency in a pair of siblings: clinical presentation, phenotypic and genotypic features, prenatal diagnosis and treatment.

Haemophilia : the official journal of the World Federation of Hemophilia·2007
Same author

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.

Cancer gene therapy·2005
Same journal

A comparison of five statistical methods used to analyse longitudinal EORTC QLQ-C30 quality of life scores in randomised controlled trials: a simulation study.

Journal of clinical epidemiology·2026
Same journal

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
Same journal

Corrigendum to SPICE-GRADE: simultaneous processing of indirect causal evidence in complex pathways using GRADE - an exploratory case study. [Journal of Clinical Epidemiology, 194C (2026) 112219].

Journal of clinical epidemiology·2026
Same journal

Small numbers of clusters in cluster randomised trials: a scoping review of problems and proposed solutions.

Journal of clinical epidemiology·2026
See all related articles

This study introduces a cancer screening model that quantines how early detection advances diagnosis timing, potentially lowering cancer stage at diagnosis. This model aids in understanding randomized controlled trial (RCT) outcomes for improved cancer screening strategies.

Area of Science:

  • Oncology
  • Biostatistics
  • Health Services Research

Background:

  • Cancer screening aims to detect malignancies earlier, potentially improving patient outcomes.
  • Randomized controlled trials (RCTs) are crucial for evaluating cancer screening effectiveness.
  • Understanding lead-time bias and stage-shifting is vital for interpreting screening trial results.

Purpose of the Study:

  • To develop a stage-shift cancer screening model within an RCT framework.
  • To quantify external and internal stage shifts and associated mortality benefits.
  • To elucidate interrelationships of benefits for better understanding of screening trial outcomes.

Main Methods:

  • Development of a mathematical model to simulate stage shifts due to screening detection.

Related Experiment Videos

  • Estimation of external (stage reduction) and internal (earlier diagnosis within stage) shifts.
  • Application of the model to data from a completed breast cancer screening RCT.

    • Main Results:

    • The model quantifies the impact of screening on advancing cancer diagnosis timing and stage.
    • External and internal stage shifts and their mortality benefits are estimated at each stage.
    • The model's application improved the interpretation of the breast cancer screening RCT data.

    Conclusions:

    • The developed stage-shift model provides a framework for analyzing cancer screening RCTs.
    • It enhances understanding of how screening influences diagnosis stage and mortality benefits.
    • The model is valuable for interpreting screening trial results and optimizing cancer detection strategies.